NV Genomics Private Limited
About NV Genomics Private Limited
Data last updated:
NV Genomics Private Limited is a private limited company based in New, Delhi, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 23 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2016PTC298380. Its GSTIN is 07AAFCN2080F1ZO (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Neena Dhiman and Vivek Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 95 Dda Pocket – 3 Dwarka Sector – 19, New, Delhi, India – 110075.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.73 Cr, a decline of 34% compared to the previous year. For the same year it recorded a net profit of ₹2.35 Lakh (net margin 1.4%) and EBITDA of ₹6.04 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years and 18% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social Media
- Registered Address95 Dda Pocket – 3 Dwarka Sector – 19, New, Delhi, India – 110075
- IndustryTrading, Retail Trading, Retailers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of NV Genomics Private Limited
The main business activity of NV Genomics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of NV Genomics Private Limited FY 2025 filings available
NV Genomics Private Limited reported revenue of ₹1.73 Cr (down 34% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of NV Genomics Private Limited
Revenue fell 34% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 18%. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of NV Genomics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.04 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.35 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of NV Genomics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of NV Genomics are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of NV Genomics Private Limited
NV Genomics Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Genomics). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Acrannolife Genomics Private Limited | •••• | •••• | •••• | •••• | 24 | Chennai, Tamil Nadu, India |
| Yikon Genomics India Private Limited | •••• | •••• | •••• | •••• | - | Haveli, Maharashtra, India |
| Bengaluru Genomics Center Private Limited | •••• | •••• | •••• | •••• | - | Bangalore, Karnataka, India |
| Micro Genomics India Private Limited | •••• | •••• | •••• | •••• | - | Chennai, Tamil Nadu, India |
| Advanced Genomics Institute & Laboratory Medicine Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| NV Genomics Private Limited this company | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Diverse Genomics Private Limited | •••• | •••• | •••• | •••• | - | Koklata, West Bengal, India |
| Nutri Genomics Private Limited | •••• | •••• | •••• | •••• | - | Kadavanthra, Kerala, India |
| Applied Genomics Private Limited | •••• | •••• | •••• | •••• | - | Coimbatore, Tamil Nadu, India |
| Answer Genomics Private Limited | •••• | •••• | •••• | •••• | - | Bangalore North, Karnataka, India |
| Cordon Genomics Private Limited | •••• | •••• | •••• | •••• | - | Lucknow, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below NV Genomics by revenue in the Biotechnology industry (Genomics), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of NV Genomics Private Limited
NV Genomics Private Limited is audited by SETHI AGARWAL AND ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SETHI AGARWAL AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of NV Genomics Private Limited
NV Genomics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neena Dhiman Also directs: Bio-Connect Research Private Limited | Director | 23 Apr 2016 | 10 Years 5 Months | Current |
| Vivek Kumar Also directs: Bio-Connect Research Private Limited | Director | 23 Apr 2016 | 10 Years 5 Months | Current |
Ownership and Shareholding of NV Genomics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of NV Genomics Private Limited
NV Genomics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at NV Genomics Private Limited
Employment history and EPFO contributions of people linked to NV Genomics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on NV Genomics Private Limited
NV Genomics Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Neena Dhiman was appointed as Director on 23 Apr 2016.
Credit Ratings, Litigation & Regulatory Alerts for NV Genomics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by NV Genomics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of NV Genomics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of NV Genomics Private Limited
NV Genomics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCN2080F1ZO | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of NV Genomics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NV Genomics Private Limited
NV Genomics is an active private limited company based in New, Delhi, India. The company works in retail trading, within the trading industry. It was incorporated on 23 April 2016 (10+ years old) and is registered under CIN U74900DL2016PTC298380.
NV Genomics reported revenue of ₹1.73 Cr for FY 2025 (down 34% YoY).
NV Genomics has 2 current directors:
- Neena Dhiman - Director
- Vivek Kumar - Director
NV Genomics reported a net profit of ₹2.35 Lakh (net margin 1.4%) and EBITDA of ₹6.04 Lakh (EBITDA margin 3.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of NV Genomics is 52% over three years and 18% over five years. In the latest year (FY 2025) revenue fell 34%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of NV Genomics is 07AAFCN2080F1ZO, registered in Delhi.
The CIN (Corporate Identification Number) of NV Genomics is U74900DL2016PTC298380. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
NV Genomics was incorporated on 23 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of NV Genomics by revenue are Acrannolife Genomics Private Limited, Yikon Genomics India Private Limited, Bengaluru Genomics Center Private Limited, Micro Genomics India Private Limited, Advanced Genomics Institute & Laboratory Medicine Private Limited and 5 more, all in the Biotechnology industry (Genomics).
Neena Dhiman was appointed as Director on 23 Apr 2016. Vivek Kumar was appointed as Director on 23 Apr 2016.
The registered office of NV Genomics is at 95 Dda Pocket – 3 Dwarka Sector – 19, New, Delhi, India – 110075.